Join
Live feed
·
INSIDERFilingvia Quantisnow
Phio Pharmaceuticals Corp. logo

Chairman, Pres. & CEO Bitterman Robert J covered exercise/tax liability with 4,111 shares and was granted 250,000 shares, increasing direct ownership by 963% to 271,421 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHIO (Phio Pharmaceuticals Corp.) and more on Quantisnow.